Qnovia
Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals
📍 Richmond, United States · Drug Delivery
Funding snapshot
Last roundSeries B
Amount$16M
Date29 October 2024
About
Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals. The company's products include "RespiRx" a combination drug product for first inhalable prescription NRT (Nicotine Replacement Therapy) for smokers trying to quit smoking and a vibrating mesh nebulizer for optimal delivery to the lungs.
Latest news
No articles yet.